British Journal of Cancer - Table of Contents alert Volume 114 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 114, Issue 9 (953-1068) Published online 26 April 2016 In this issue Editorial Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement BJC collections: Cancer Immunotherapy Immunotherapies have revolutionised therapy for some cancers. In parallel with therapeutic trials, many other mechanisms and pathways are being investigated in optimising these treatments.  Access this collection from British Journal of Cancer - free online for six months Produced with support from: EMD Serono   Editorial Top Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress Patricia A Ganz Br J Cancer 2016 114: 953-955; 10.1038/bjc.2016.89 Full Text Clinical Studies Top Adjuvant ovarian function suppression and cognitive function in women with breast cancer Kelly-Anne Phillips, Meredith M Regan, Karin Ribi, Prudence A Francis, Fabio Puglisi, Meritxell Bellet, Simon Spazzapan, Per Karlsson, Daniel R Budman, Khalil Zaman, Ehtesham A Abdi, Susan M Domchek, Yang Feng, Karen N Price, Alan S Coates, Richard D Gelber, Paul Maruff, Frances Boyle, John F Forbes, Tim Ahles, Gini F Fleming and Jürg Bernhard for the Co-SOFT investigators Br J Cancer 2016 114: 956-964; advance online publication, April 19, 2016; 10.1038/bjc.2016.71 Abstract | Full Text Quality of life, long-term survivors and long-term outcome from the ABC-02 study John Bridgewater, Andre Lopes, Daniel Palmer, David Cunningham, Alan Anthoney, Anthony Maraveyas, Srinivasan Madhusudan, Tim Iveson, Juan Valle and Harpreet Wasan on behalf of the ABC-02 investigators Br J Cancer 2016 114: 965-971; 10.1038/bjc.2016.64 Abstract | Full Text Effect of leaving chronic oral foci untreated on infectious complications during intensive chemotherapy J M Schuurhuis, L F R Span, M A Stokman, A J van Winkelhoff, A Vissink and F K L Spijkervet Br J Cancer 2016 114: 972-978; advance online publication, March 22, 2016; 10.1038/bjc.2016.60 Abstract | Full Text Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation Olivia Wu, Kathleen Boyd, Jim Paul, Elaine McCartney, Moira Ritchie, D Mellon, Linda Kelly, Judith Dixon-Hughes and Jon Moss Br J Cancer 2016 114: 979-985; advance online publication, April 19, 2016; 10.1038/bjc.2016.76 Abstract | Full Text Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours D Mahalingam, G Wilding, S Denmeade, J Sarantopoulas, D Cosgrove, J Cetnar, N Azad, J Bruce, M Kurman, V E Allgood and M Carducci Br J Cancer 2016 114: 986-994; 10.1038/bjc.2016.72 Abstract | Full Text Translational Therapeutics Top Soluble tumour necrosis factor receptor type II and survival in colorectal cancer Ana Babic, Sonali M Shah, Mingyang Song, Kana Wu, Jeffrey A Meyerhardt, Shuji Ogino, Chen Yuan, Edward L Giovannucci, Andrew T Chan, Meir J Stampfer, Charles S Fuchs and Kimmie Ng Br J Cancer 2016 114: 995-1002; advance online publication, March 31, 2016; 10.1038/bjc.2016.85 Abstract | Full Text Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies Naoki Takahashi, Satoru Iwasa, Hirokazu Taniguchi, Yusuke Sasaki, Hirokazu Shoji, Yoshitaka Honma, Atsuo Takashima, Natsuko Okita, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada and Yasuhide Yamada Br J Cancer 2016 114: 1003-1011; advance online publication, March 22, 2016; 10.1038/bjc.2016.74 Abstract | Full Text Molecular Diagnostics Top Loss of the cell polarity determinant human Discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancer Takeru Sugihara, Shunsuke Nakagawa, Yuko Sasajima, Takayuki Ichinose, Haruko Hiraike, Fukuo Kondo, Hiroshi Uozaki, Toshio Fukusato and Takuya Ayabe Br J Cancer 2016 114: 1012-1018; advance online publication, March 22, 2016; 10.1038/bjc.2016.24 Abstract | Full Text Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion Simon A Fry, Claire E Robertson, Ruth Swann and Miriam V Dwek Br J Cancer 2016 114: 1019-1026; advance online publication, March 24, 2016; 10.1038/bjc.2016.66 Abstract | Full Text Epidemiology Top Predictive value of mucinous histology in colon cancer: a population-based, propensity score matched analysis Rene Warschkow, Ignazio Tarantino, Felix J Huttner, Bruno M Schmied, Ulrich Guller, Markus K Diener and Alexis Ulrich Br J Cancer 2016 114: 1027-1032; advance online publication, March 15, 2016; 10.1038/bjc.2016.57 Abstract | Full Text Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study Kezia Gaitskell, Kate Coffey, Jane Green, Kirstin Pirie, Gillian K Reeves, Ahmed A Ahmed, Isobel Barnes and Valerie Beral on behalf of the Million Women Study Collaborators3 Br J Cancer 2016 114: 1033-1037; advance online publication, April 21, 2016; 10.1038/bjc.2016.80 Abstract | Full Text Impact of organised mammography screening on breast cancer mortality in a case–control and cohort study Sirpa Heinävaara, Tytti Sarkeala and Ahti Anttila Br J Cancer 2016 114: 1038-1044; advance online publication, March 24, 2016; 10.1038/bjc.2016.68 Abstract | Full Text Breast cancer risk feedback to women in the UK NHS breast screening population D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham, Michelle N Harvie, Mary Wilson, Ursula Beetles, Iain Buchan, Adam R Brentnall, David P French, Jack Cuzick and Anthony Howell Br J Cancer 2016 114: 1045-1052; advance online publication, March 29, 2016; 10.1038/bjc.2016.56 Abstract | Full Text The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients Jente van Staalduinen, Martine Frouws, Marlies Reimers, Esther Bastiaannet, Myrthe P P van Herk-Sukel, Valery Lemmens, Wobbe O de Steur, Henk H Hartgrink, Cornelis J H van de Velde and Gerrit-Jan Liefers Br J Cancer 2016 114: 1053-1059; advance online publication, April 7, 2016; 10.1038/bjc.2016.65 Abstract | Full Text Educational and occupational outcomes of childhood cancer survivors 30 years after diagnosis: a French cohort study Agnes Dumas, Claire Berger, Pascal Auquier, Gérard Michel, Brice Fresneau, Rodrigue Sètchéou Allodji, Nadia Haddy, Carole Rubino, Gilles Vassal, Dominique Valteau-Couanet, Sandrine Thouvenin-Doulet, Léonie Casagranda, Hélène Pacquement, Chiraz El-Fayech, Odile Oberlin, Catherine Guibout and Florent de Vathaire Br J Cancer 2016 114: 1060-1068; 10.1038/bjc.2016.62 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.